摘要
目的探讨复方丹参片联合多奈哌齐治疗阿尔茨海默病(AD)的安全性和有效性。方法选取广西壮族自治区江滨医院AD患者共100例,随机数字表法分为观察组和对照组,每组50例。对照组给予多奈哌齐治疗,观察组给予复方丹参片联合多奈哌齐治疗。观察组与对照组治疗前、治疗后1个月、治疗后3个月的简易精神状态量表(MMSE)评分、AD认知功能评定量表(ADAS-cog)评分、日常生活能力量表(ADL)评分、血清谷氨酸(Glu)水平、血清天冬氨酸(Asp)水平,均采用重复测量设计的方差分析。统计不良反应发生率。结果 (1)不同时间点间的MMSE评分、ADAS-cog评分、ADL评分、血清Glu水平、血清Asp水平有差异(P<0.05)。(2)观察组与对照组的MMSE评分、ADAS-cog评分、ADL评分、血清Glu水平、血清Asp水平有差异(P<0.05),观察组与对照组比较MMSE评分较高,ADAS-cog评分、ADL评分、血清Glu水平、血清Asp水平较低。(3)观察组与对照组的MMSE评分、ADAS-cog评分、ADL评分、血清Glu水平、血清Asp水平变化趋势有差异(P<0.05)。观察组和对照组不良反应发生率比较,差异无统计学意义(P<0.05)。结论复方丹参片联合多奈哌齐治疗AD的效果确切,其机制可能与抑制兴奋性氨基酸表达有关。
Objective To evaluate the efficacy and safety of compound Danshen tablets combined with Donepezil on Alzheimer's disease(AD).Methods One hundred AD patients were randomly divided into an observation group and a control group,with 50 cases in each group.The control group was treated with Donepezil,and the observation group was treated with compound Danshen tablets combined with Donepezil.Before treatment,1 month and 3 months after treatment,Mini-mental State Examination(MMSE)score,Alzheimer’s Disease Assessment Scale(ADAS-cog)score,activities of daily living(ADL)score,glutamic acid(Glu)level and aspartic acid(Asp)level of the two groups were analyzed by repeated measures.The incidences of adverse reactions of the two groups were counted.Results The MMSE score,ADAS-cog score,ADL score,serum Glu and Asp levels were different at different time points(P<0.05).The MMSE score,ADAS-cog score,ADL score,serum Glu and Asp levels were different between the observation group and the control group(P<0.05),the MMSE score of the observation group was higher than that of the control group,while the ADAS-cog score,ADL score,serum Glu and Asp levels of the observation group were lower than those of the control group.The variation trends of MMSE score,ADAS-cog score,ADL score,serum Glu and Asp levels were different at different time points(P<0.05).The adverse reaction rate was not statistically different between the two groups(P>0.05).Conclusions Compound Danshen tablets combined with Donepezil is effective for AD,its mechanism may be related to the inhibition of excitatory amino acid expression.
作者
张为
胡才友
吕渊
付棉
梁梅
Wei Zhang;Cai-you Hu;Yuan Lü;Mian Fu;Mei Liang(Department of Neurology,Jiangbin Hospital of Guangxi Zhuang Autonomous Region,Nanning,Guangxi 530021,China)
出处
《中国现代医学杂志》
CAS
2018年第25期37-40,共4页
China Journal of Modern Medicine
基金
国家自然科学基金(No:81460203)
关键词
复方丹参片
多奈哌齐
阿尔茨海默病
兴奋性氨基酸
compound Danshen tablets
Donepezil
Alzheimer's disease
excitatory amino acid